• About Lareb
    About Lareb
  • Search information about ADRs
    Search information about ADRs
  • Subscribe to newsletter
    Subscribe to newsletter

News updates

  • 12 APR
    Fatigue associated with biologics

    Fatigue is a common symptom in patients with inflammatory immune diseases. Patients may also experience fatigue as an adverse drug reaction of biologics used for an immune-mediated inflammatory diseas...

    Read more
  • 04 APR
    Inhalation of small capsule pieces through an inhaler is not harmful

    Puncturing powder capsules for inhalation may cause small capsule pieces to break loose. Capsule pieces that are small enough to pass through the filter are sometimes inhaled when using the inhaler. ...

    Read more
  • 10 MAR
    Guillain-Barré Syndrome after COVID-19 vaccination

    Until October 12th 2022, the Netherlands Pharmacovigilance Centre Lareb received 72 reports of  Guillain-Barré Syndrome (GBS) following COVID-19 vaccination. GBS is labeled as a rare side effect of th...

    Read more
  • 15 FEB
    Propylthiouracil and ANCA vasculitis

    The Netherlands Pharmacovigilance Centre Lareb received seven well-documented reports on propylthiouracil and anti-neutrophil cytoplasmic antibody (ANCA) positive vasculitis. Propylthiouracil is an a...

    Read more
  • 13 FEB
    Call for abstracts for the ISoP Mid-Year Symposium 2023

    This year the ISoP mid-year meeting will be hosted by the Netherlands Pharmacovigilance Centre Lareb on 1-2 June 2023 in Leiden, the Netherlands. This meeting will focus on connecting the multiple sci...

    Read more
  • 07 FEB
    Higher probability of experiencing a side effect in women after COVID-19 vaccination

    Females have a two-fold higher odds of experiencing an adverse event following immunization (AEFI) than males after a COVID-19 vaccination. This difference was greater after the first COVID-19 vaccina...

    Read more